Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice
- PMID: 15737665
- DOI: 10.1016/j.biopsych.2004.11.046
Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice
Abstract
Background: Reelin and GAD(67) expression is downregulated in cortical interneurons of schizophrenia (SZ) patients. This downregulation is probably mediated by epigenetic hypermethylation of the respective promoters caused by the selective increase of DNA-methyltransferase 1 in GABAergic neurons. Mice receiving methionine (MET) provide an epigenetic model for neuropathologies related to SZ. We studied whether MET-induced epigenetic reelin promoter hypermethylation and the associated behavioral alterations can be reduced by valproate in doses that inhibit histone deacetylases (HDACs).
Methods: Mice treated with either methionine (MET) (5.2 mmol/kg/SC/twice daily) or valproate (1.5 mmol/kg/SC/twice daily) or MET+ valproate combination were tested for prepulse inhibition of startle (PPI) and social interaction (SI). S-adenosylmethionine, acetylated histone 3, reelin promoter methylation, and reelin mRNA were assayed in the frontal cortex.
Results: Valproate enhances acetylated histone 3 content, and prevents MET-induced reelin promoter hypermethylation, reelin mRNA downregulation, and PPI and SI deficits. Imidazenil, a positive allosteric modulator at GABA(A) receptors containing alpha(5) subunits but inactive at receptors including alpha(1) subunits, normalizes MET-induced behavioral changes.
Conclusion: This MET-induced epigenetic mouse models the neurochemical and behavioral aspects of SZ that can be corrected by positively modulating the action of GABA at alpha(5)-containing GABA(A) receptors with imidazenil or by inhibiting HDACs with valproate, thus opening exciting new avenues for treatment of epigenetically modified chromatin in SZ morbidity.
Similar articles
-
Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling.Trends Pharmacol Sci. 2009 Feb;30(2):55-60. doi: 10.1016/j.tips.2008.10.010. Epub 2008 Dec 26. Trends Pharmacol Sci. 2009. PMID: 19110320
-
Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12578-83. doi: 10.1073/pnas.0505394102. Epub 2005 Aug 19. Proc Natl Acad Sci U S A. 2005. PMID: 16113080 Free PMC article.
-
The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.Pharmacol Ther. 2006 Jul;111(1):272-86. doi: 10.1016/j.pharmthera.2005.01.007. Epub 2006 Mar 30. Pharmacol Ther. 2006. PMID: 16574235 Review.
-
Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters.Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4676-81. doi: 10.1073/pnas.0700529104. Epub 2007 Mar 7. Proc Natl Acad Sci U S A. 2007. PMID: 17360583 Free PMC article.
-
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.Psychopharmacology (Berl). 2005 Jul;180(2):191-205. doi: 10.1007/s00213-005-2212-8. Epub 2005 Apr 28. Psychopharmacology (Berl). 2005. PMID: 15864560 Review.
Cited by
-
Effect of valproic acid on mitochondrial epigenetics.Eur J Pharmacol. 2012 Sep 5;690(1-3):51-9. doi: 10.1016/j.ejphar.2012.06.019. Epub 2012 Jun 20. Eur J Pharmacol. 2012. PMID: 22728245 Free PMC article.
-
Insight from animal models of environmentally driven epigenetic changes in the developing and adult brain.Dev Psychopathol. 2016 Nov;28(4pt2):1229-1243. doi: 10.1017/S095457941600081X. Epub 2016 Sep 30. Dev Psychopathol. 2016. PMID: 27687803 Free PMC article. Review.
-
Efficacy of 3,5-dibromo-L-phenylalanine in rat models of stroke, seizures and sensorimotor gating deficit.Br J Pharmacol. 2009 Dec;158(8):2005-13. doi: 10.1111/j.1476-5381.2009.00498.x. Br J Pharmacol. 2009. PMID: 20050189 Free PMC article.
-
5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients.Psychopharmacology (Berl). 2014 Sep;231(17):3569-80. doi: 10.1007/s00213-014-3567-5. Epub 2014 Apr 30. Psychopharmacology (Berl). 2014. PMID: 24781515 Free PMC article.
-
DNA methylation in schizophrenia: progress and challenges of epigenetic studies.Genome Med. 2012 Dec 13;4(12):96. doi: 10.1186/gm397. eCollection 2012. Genome Med. 2012. PMID: 23234572 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous